Patients that experienced CSMEs had a trend toward more post-transplant readmissions ( median 1 [ interquartile range ( IQR ) , 0-5 ] versus 0 [ 0-2 ] ; P = 0.06 ) , higher costs for readmissions ( median $ 18,091 [ IQR , $ 3023 - $ 56,268 ] versus $ 0 [ $ 0 - $ 15,991 ] ; P < 0.01 ) , and overall length of stay ( median 5.0 days [ IQR , 2.0-14 .0 ] versus 0.0 days [ IQR , 0.0-5 .5 ] ; P < 0.01 ) after the CSME event .